| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.16B | 1.11B | 971.52M | 1.03B | 927.42M |
| Gross Profit | 321.97M | 459.21M | 387.86M | 373.81M | 333.68M |
| EBITDA | 123.37M | 121.74M | 97.99M | 107.09M | 95.51M |
| Net Income | 76.46M | 65.07M | 50.49M | 59.75M | 58.63M |
Balance Sheet | |||||
| Total Assets | 940.94M | 974.81M | 810.07M | 842.70M | 831.91M |
| Cash, Cash Equivalents and Short-Term Investments | 90.44M | 122.92M | 99.44M | 15.85M | 20.61M |
| Total Debt | 114.18M | 118.77M | 127.30M | 209.24M | 200.93M |
| Total Liabilities | 466.55M | 530.54M | 455.12M | 475.87M | 490.93M |
| Stockholders Equity | 461.77M | 431.49M | 340.95M | 355.53M | 337.56M |
Cash Flow | |||||
| Free Cash Flow | 2.62M | 51.70M | 197.44M | 32.15M | -168.92M |
| Operating Cash Flow | 19.70M | 70.00M | 211.68M | 40.77M | -151.44M |
| Investing Cash Flow | -16.52M | -21.06M | -18.90M | -26.91M | -17.38M |
| Financing Cash Flow | -27.95M | -29.22M | -102.76M | -14.46M | 146.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €133.21M | 15.10 | 12.93% | 2.01% | 3.02% | 4.64% | |
70 Outperform | €1.31B | 12.82 | 6.71% | 2.46% | 8.50% | 97.84% | |
69 Neutral | €831.11M | 10.86 | 17.61% | 1.82% | 1.99% | -22.69% | |
62 Neutral | €151.95M | 83.16 | 2.14% | 7.77% | -10.49% | -74.90% | |
60 Neutral | €1.29B | 9.34 | 6.50% | 2.88% | 3.77% | -1.75% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |